Branded

LAVAL, Quebec — Valeant Pharmaceuticals International, a specialty pharmaceutical company, on Friday announced that it received approval from the Food and Drug Administration for Retin-A Micro (tretinoin) gel microsphere 0.08%, which is used for the topical treatment of acne vulgaris.

PITTSBURGH and MUMBAI, India — Mylan announced that its India-based subsidiary, Mylan Pharmaceuticals Private Limited, has been named Gilead Sciences' branded medicines business partner for India.

Under this exclusive agreement, Mylan will market and distribute in India the following drugs from Gilead:

CAMP HILL, Pa. — Rite Aid's January same-store sales increased 1.8%, beating out an analyst projection of a 0.5% increase in overall comparable-store sales. Total drug store sales for the four weeks ended Jan. 25 increased 1.5% to $1.9 billion.

January front-end same-store sales decreased 1.3%, of which 1.4% was attributable to a decrease in sales of flu-related over-the-counter products. Pharmacy same-store sales, which included an approximate 124 basis points negative impact from new generic introductions, increased 3.2%. 

JERUSALEM — Teva Pharmaceutical Industries on Tuesday announced that the Food and Drug Administration approved its supplemental new drug application for three-times-a-week Copaxone in 40mg/mL. Daily Copaxone in 20mg/mL dosage will continue to be available.  

Copaxone is administered to patients with relapsing forms of multiple sclerosis. The new formulation will allow for a less frequent dosing regimen.

In 2012, compounding made headlines when 64 people died as a result of fungal meningitis caused by contaminated compounded products.

History

Pharmacists and nurse practitioners are trusted healthcare professionals who provide instructions and advice based on peer-reviewed guidelines and clinical data. They have the opportunity and responsibility to educate patients about the benefits of childhood vaccines and to be advocates for immunizations as they relate to public health. Immunizations remain one of the most important public health discoveries of all time and are responsible for the decreased amount of infectious disease.

The same H1N1 virus to cause a pandemic in 2009 is by far the predominant influenza virus for the 2013-2014 season. This is the first season that the H1N1 virus has circulated at high levels since the pandemic.

However, the Northern Hemisphere quadrivalent and trivalent vaccines for the 2013-2014 season are well-matched to the H1N1 virus in circulation, according to the Centers for Disease Control and Prevention’s FluView report for the week ended Jan. 4.

What’s at the root of most morbidity and mortality from influenza and other vaccine-preventable diseases? Under-immunization. Retail clinicians (i.e., nurse practioners, physician assistants and doctors) are in a unique position to influence immunization rates by educating patients on the benefits of appropriate vaccines.